The dossier of Edoxaban is available for B2B partners!
Partnership in the treatment of thromboembolic disease
The dossier of Apremilast is available for B2B partners!
Zent2U would like to announce to all our B2B business partners that the Rivaroxaban Oral Suspension dossier is ready and we are now able to offer the product for out-licensing in selected markets in Europe on an exclusive or semi-exclusive base. The dossier can also be adjusted to markets outside Europe based on request. ???
Growth can’t be stopped. Zentiva’s commitment is to offer affordable, high-quality products and hassle-free services. Especially when it comes to Zentiva’s specialization in sterile production such as ointments, vials, and ampoules.
Joint investment in the new aseptic line
Cabo Da Roca is the westernmost point of continental Europe. Only a few kilometers southeast lies Lisbon. A lovely city with delicious Pastéis de Nata hosts our favorite Marketplace for Pharma Business Opportunities euroPLX.
Successful pivotal bioequivalence study results on Omeprazole Immediate Release Capsules
On Thursday 23rd starts our favorite two-day conference PharmaSynergy. And Zent2U will be there.